A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity

<p>Abstract</p> <p>Background</p> <p>Prostaglandin H<sub>2 </sub>synthase (PGHS) is the enzyme that catalyses the two-stage conversion of arachidonic acid to prostaglandin H<sub>2 </sub>(PGH<sub>2</sub>) prior to formation of prostano...

Full description

Bibliographic Details
Main Authors: Rossi Adriano G, McClure Danny, Turnbull Catriona M, Megson Ian L
Format: Article
Language:English
Published: BMC 2006-09-01
Series:Journal of Inflammation
Online Access:http://www.journal-inflammation.com/content/3/1/12
id doaj-814b72eff27a4d04a61b7f40decc85d2
record_format Article
spelling doaj-814b72eff27a4d04a61b7f40decc85d22020-11-24T22:06:27ZengBMCJournal of Inflammation1476-92552006-09-01311210.1186/1476-9255-3-12A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activityRossi Adriano GMcClure DannyTurnbull Catriona MMegson Ian L<p>Abstract</p> <p>Background</p> <p>Prostaglandin H<sub>2 </sub>synthase (PGHS) is the enzyme that catalyses the two-stage conversion of arachidonic acid to prostaglandin H<sub>2 </sub>(PGH<sub>2</sub>) prior to formation of prostanoids that are important in inflammation. PGHS isozymes (-1 and -2) are the target for nonsteroidal anti-inflammatory drugs (NSAIDs).</p> <p>Given the rekindled interest in specific anti-inflammatory PGHS inhibitors with reduced unwanted side effects, it is of paramount importance that there are reliable and efficient techniques to test new inhibitors. Here, we describe a novel <it>in vitro </it>electron paramagnetic resonance (EPR)-based assay for measuring the activity of PGHS-1.</p> <p>Methods</p> <p>We validated a novel <it>in vitro </it>PGHS-1 activity assay based on the oxidation of spin-trap agent, 1-hydroxy-3-carboxy-pyrrolidine (CPH) to 3-carboxy-proxy (CP) under the action of the peroxidase element of PGHS-1. This quantifiable spin-adduct, CP, yields a characteristic 3-line electron paramagnetic (EPR) spectrum.</p> <p>Results</p> <p>The assay is simple, reproducible and facilitates rapid screening of inhibitors of PGHS-1. Aspirin (100 μM, 1 mM) caused significant inhibition of spin-adduct formation (72 ± 11 and 100 ± 16% inhibition of control respectively; P < 0.05). Indomethacin (100 μM) also abolished the signal (114 ± 10% inhibition of control; P < 0.01). SA and the PGHS-2-selective inhibitor, NS398, failed to significantly inhibit spin-adduct generation (P > 0.05).</p> <p>Conclusion</p> <p>We have demonstrated and validated a simple, reproducible, quick and specific assay for detecting PGHS-1 activity and inhibition. The EPR-based assay described represents a novel approach to measuring PGHS activity and provides a viable and competitive alternative to existing assays.</p> http://www.journal-inflammation.com/content/3/1/12
collection DOAJ
language English
format Article
sources DOAJ
author Rossi Adriano G
McClure Danny
Turnbull Catriona M
Megson Ian L
spellingShingle Rossi Adriano G
McClure Danny
Turnbull Catriona M
Megson Ian L
A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
Journal of Inflammation
author_facet Rossi Adriano G
McClure Danny
Turnbull Catriona M
Megson Ian L
author_sort Rossi Adriano G
title A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
title_short A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
title_full A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
title_fullStr A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
title_full_unstemmed A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity
title_sort novel electron paramagnetic resonance-based assay for prostaglandin h synthase-1 activity
publisher BMC
series Journal of Inflammation
issn 1476-9255
publishDate 2006-09-01
description <p>Abstract</p> <p>Background</p> <p>Prostaglandin H<sub>2 </sub>synthase (PGHS) is the enzyme that catalyses the two-stage conversion of arachidonic acid to prostaglandin H<sub>2 </sub>(PGH<sub>2</sub>) prior to formation of prostanoids that are important in inflammation. PGHS isozymes (-1 and -2) are the target for nonsteroidal anti-inflammatory drugs (NSAIDs).</p> <p>Given the rekindled interest in specific anti-inflammatory PGHS inhibitors with reduced unwanted side effects, it is of paramount importance that there are reliable and efficient techniques to test new inhibitors. Here, we describe a novel <it>in vitro </it>electron paramagnetic resonance (EPR)-based assay for measuring the activity of PGHS-1.</p> <p>Methods</p> <p>We validated a novel <it>in vitro </it>PGHS-1 activity assay based on the oxidation of spin-trap agent, 1-hydroxy-3-carboxy-pyrrolidine (CPH) to 3-carboxy-proxy (CP) under the action of the peroxidase element of PGHS-1. This quantifiable spin-adduct, CP, yields a characteristic 3-line electron paramagnetic (EPR) spectrum.</p> <p>Results</p> <p>The assay is simple, reproducible and facilitates rapid screening of inhibitors of PGHS-1. Aspirin (100 μM, 1 mM) caused significant inhibition of spin-adduct formation (72 ± 11 and 100 ± 16% inhibition of control respectively; P < 0.05). Indomethacin (100 μM) also abolished the signal (114 ± 10% inhibition of control; P < 0.01). SA and the PGHS-2-selective inhibitor, NS398, failed to significantly inhibit spin-adduct generation (P > 0.05).</p> <p>Conclusion</p> <p>We have demonstrated and validated a simple, reproducible, quick and specific assay for detecting PGHS-1 activity and inhibition. The EPR-based assay described represents a novel approach to measuring PGHS activity and provides a viable and competitive alternative to existing assays.</p>
url http://www.journal-inflammation.com/content/3/1/12
work_keys_str_mv AT rossiadrianog anovelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT mccluredanny anovelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT turnbullcatrionam anovelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT megsonianl anovelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT rossiadrianog novelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT mccluredanny novelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT turnbullcatrionam novelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
AT megsonianl novelelectronparamagneticresonancebasedassayforprostaglandinhsynthase1activity
_version_ 1725823667938525184